Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05453825
Title A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors OncXerna Theraputics, Inc.
Indications

ovary epithelial cancer

peritoneum cancer

stomach cancer

fallopian tube cancer

rectum adenocarcinoma

colorectal cancer

colon adenocarcinoma

gastroesophageal junction adenocarcinoma

triple-receptor negative breast cancer

Therapies

Irinotecan + Navicixizumab

Navicixizumab

Navicixizumab + Paclitaxel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Genesis Cancer Center Recruiting Hot Springs Arkansas 71913 United States Details
Northside Hospital Recruiting Atlanta Georgia 30322 United States Details
Hematology Oncology Clinic Recruiting Baton Rouge Louisiana 70809 United States Details
University of Michigan Recruiting Ann Arbor Michigan 48109 United States Details
New York University - Langone Health - Perlmutter Cancer Center Recruiting New York New York 10016 United States Details
The Zangmeister Cancer Center Recruiting Columbus Ohio 43219 United States Details
Tennessee Oncology Recruiting Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field